M. Viguier

5.2k total citations · 1 hit paper
125 papers, 3.0k citations indexed

About

M. Viguier is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, M. Viguier has authored 125 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 48 papers in Dermatology and 30 papers in Rheumatology. Recurrent topics in M. Viguier's work include Psoriasis: Treatment and Pathogenesis (30 papers), Autoimmune Bullous Skin Diseases (23 papers) and Dermatology and Skin Diseases (21 papers). M. Viguier is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (30 papers), Autoimmune Bullous Skin Diseases (23 papers) and Dermatology and Skin Diseases (21 papers). M. Viguier collaborates with scholars based in France, United States and Germany. M. Viguier's co-authors include H. Bachelez, Louis Dubertret, Fabrice Lemaı̂tre, Laurent Ferradini, Philippe Kourilsky, O Vérola, Guy Gorochov, Laurence Michel, Célèste Lebbé and Patrice Morel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

M. Viguier

117 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells

2004 561 citations M. Viguier, Fabrice Lemaı̂tre et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by M. Viguier

Since Specialization

Citations

This map shows the geographic impact of M. Viguier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Viguier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Viguier more than expected).

Fields of papers citing papers by M. Viguier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Viguier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Viguier. The network helps show where M. Viguier may publish in the future.

Co-authorship network of co-authors of M. Viguier

This figure shows the co-authorship network connecting the top 25 collaborators of M. Viguier. A scholar is included among the top collaborators of M. Viguier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Viguier. M. Viguier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature 2024 ·Acta Dermato Venereologica ·C. Vanhaecke, M. Viguier	0
2	Generalized pustular psoriasis: A nationwide population‐based study using the National Health Data System in France 2024 ·Journal of the European Academy of Dermatology and Venereology ·M. Viguier, Malek Bentayeb, (unknown), Gérard de Pouvourville, (unknown), (unknown), Jacques Massol, (unknown), Christian Thoma, H. Bachelez	9
3	Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study 2023 ·Journal of the American Academy of Dermatology ·(unknown), Emmanuelle Tancrède‐Bohin, M. Alexandre, S. Oro, (unknown), S. Debarbieux, S. Duvert‐Lehembre, Maria Polina Konstantinou, C. Abasq, (unknown), (unknown), C. Lepelletier, (unknown), (unknown), (unknown), (unknown), F. Caux, P. Joly, (unknown), M. Viguier	2
4	3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System 2023 ·Science Advances ·(unknown), Raïssa Houmadi, (unknown), Nadine Serhan, M. Tauber, (unknown), Lilian Basso, (unknown), Pascal Descargues, M. Viguier, Cécile Lesort, B. Chaput, Jean Kanitakis, D. Jullien, C. Bulaï Livideanu, Laurence Lamant, Emeline Pagès, Nicolas Gaudenzio	6
5	Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort 2023 ·Annales de Dermatologie et de Vénéréologie ·(unknown), E. Mahé, M.‐A. Richard, Yann De Rycke, M. Viguier, M. Beylot‐Barry, A. Dupuy, N. Bénéton, P. Joly, D. Jullien, H. Bachelez, É. Sbidian, O. Chosidow, C. Paul, Florence Tubach	1
6	Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review 2022 ·Journal of the European Academy of Dermatology and Venereology ·Jörg C. Prinz, Siew Eng Choon, C.E.M. Griffiths, Joseph F. Merola, Akimichi Morita, Darren M. Ashcroft, M. Viguier	55
7	Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study 2022 ·Arthritis & Rheumatology ·Patricia Senet, H. Maillard, Élisabeth Diot, I. Lazareth, S. Blaise, Jean‐Philippe Arnault, Marc‐Antoine Pistorius, Carine Boulon, O. Cogrel, U. Warzocha, Sébastien Rivière, (unknown), Amélie Servettaz, B. Sassolas, M. Viguier, J.‐B. Monfort, (unknown), Éric Vicaut, (unknown)	5
8	Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study 2022 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), M. Viguier, (unknown), (unknown), P. Joly, (unknown), (unknown), (unknown), N. Cordel, S. Duvert‐Lehembre, Emmanuelle Tancrède‐Bohin, Thibaut Belmondo, S. Oro, M. D’Incan	2
9	Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané 2021 ·PubMed Central ·(unknown), E. Mahé, M.‐A. Richard, (unknown), Yann De Rycke, M. Viguier, M. Beylot‐Barry, A. Dupuy, N. Bénéton, P. Joly, D. Jullien, H. Bachelez, É. Sbidian, O. Chosidow, C. Paul, Florence Tubach	1
10	Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts 2021 ·Dermatology ·(unknown), Laëtitia Penso, Viet-Thi Tran, Claire Hotz, Philippe Guillem, A. Villani, Pierre Perrot, (unknown), Eric Jacquet, Aude Nassif, H. Bachelez, P. Wolkenstein, M. Beylot‐Barry, M.‐A. Richard, Philippe Ravaud, M. Viguier, É. Sbidian	5
11	Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus 2021 ·Journal of Investigative Dermatology ·Maud Maho‐Vaillant, Corine Pérals, Marie-Laure Golinski, V. Hébert, Frédérique Caillot, C. Mignard, Gaëtan Riou, Marie Petit, M. Viguier, Michael Hertl, Olivier Boyer, Sébastien Calbo, Nicolas Fazilleau, Pascal Joly	18
12	Iatrogenic Kaposi's sarcoma in a myelofibrosis patient treated with ruxolitinib: Case‐report, literature review, and French pharmacovigilance data 2021 ·American Journal of Hematology ·(unknown), Violaine Noël, Aude Jary, Quoc‐Hung Le, (unknown), M. Viguier, Célèste Lebbé, (unknown), Firouzé Bani‐Sadr	3
13	Impact of the French guidelines on the prescribing habits of systemic treatments for moderate‐to‐severe psoriasis 2020 ·Journal of the European Academy of Dermatology and Venereology ·A. Villani, F. Amatore, M. Tauber, B. Guillot, M. Viguier, M. Beylot‐Barry, D. Jullien	2
14	IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases 2016 ·Journal of Investigative Dermatology ·M. Tauber, Élodie Bal, Xue-Yuan Pei, Marine Madrange, Amel Haj Khelil, (unknown), (unknown), Mohamed Makrelouf, (unknown), (unknown), (unknown), (unknown), (unknown), Slaheddine Marrakchi, H. Turki, E. Bourrat, M. Viguier, Yamina Hamel, H. Bachelez, Asma Smahi	71
15	Actinomycetoma 2015 ·New England Journal of Medicine ·M. Viguier, Matthieu Lafaurie	2
16	Ultrasound-guided core needle biopsy of superficial lymph nodes 2015 ·Melanoma Research ·G. Bohelay, Maxime Battistella, Cécile Pagès, Constance de Margerie‐Mellon, Nicole Basset‐Séguin, M. Viguier, Delphine Kérob, (unknown), M. Baccard, (unknown), C. Comte, Samia Mourah, Raphaël Porcher, M. Bagot, Anne Janin, É. de Kerviler, Célèste Lebbé	11
17	Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome 2009 ·British Journal of Dermatology ·L. Fardet, Lionel Galicier, Marie‐Dominique Vignon‐Pennamen, S. Régnier, (unknown), Adrienne de Labarthe, (unknown), Valérie Martinez, Sophie Buyse, M. Viguier, Amélie Osio, Célèste Lebbé, Patrice Morel, A. Dupuy, M. Rybojad	35
18	Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? 2007 ·PubMed ·Pascal Richette, M. Viguier, H. Bachelez, Thomas Bardin	20
19	Cutting Edge: Size and Diversity of CD4+CD25high Foxp3+ Regulatory T Cell Repertoire in Humans: Evidence for Similarities and Partial Overlapping with CD4+CD25− T Cells 2007 ·The Journal of Immunology ·Nicolas Fazilleau, H. Bachelez, Marie‐Lise Gougeon, M. Viguier	49
20	Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells breakdown → 2004 ·The Journal of Immunology ·M. Viguier, Fabrice Lemaı̂tre, O Vérola, (unknown), Guy Gorochov, Louis Dubertret, H. Bachelez, Philippe Kourilsky, Laurent Ferradini	561

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact